Click for best price
Mental Disorders Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Mental Disorders Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Disorders Drugs. This report contains market size and forecasts of Mental Disorders Drugs in global, including the following market information:
Global Mental Disorders Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Mental Disorders Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Mental Disorders Drugs companies in 2022 (%)
The global Mental Disorders Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Drugs for Schizophrenia Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Mental Disorders Drugs include Johnson & Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb and Abbott Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mental Disorders Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mental Disorders Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mental Disorders Drugs Market Segment Percentages, by Type, 2022 (%)
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others
Global Mental Disorders Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mental Disorders Drugs Market Segment Percentages, by Application, 2022 (%)
Children
Adolescents
Adults
Global Mental Disorders Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mental Disorders Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mental Disorders Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Mental Disorders Drugs revenues share in global market, 2022 (%)
Key companies Mental Disorders Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Mental Disorders Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Abbott Laboratories
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mental Disorders Drugs, market overview.
Chapter 2: Global Mental Disorders Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Mental Disorders Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mental Disorders Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Mental Disorders Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Mental Disorders Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Mental Disorders Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mental Disorders Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mental Disorders Drugs Overall Market Size
2.1 Global Mental Disorders Drugs Market Size: 2022 VS 2029
2.2 Global Mental Disorders Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Mental Disorders Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Mental Disorders Drugs Players in Global Market
3.2 Top Global Mental Disorders Drugs Companies Ranked by Revenue
3.3 Global Mental Disorders Drugs Revenue by Companies
3.4 Global Mental Disorders Drugs Sales by Companies
3.5 Global Mental Disorders Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Mental Disorders Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Mental Disorders Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mental Disorders Drugs Players in Global Market
3.8.1 List of Global Tier 1 Mental Disorders Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Mental Disorders Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Mental Disorders Drugs Market Size Markets, 2022 & 2029
4.1.2 Drugs for Schizophrenia
4.1.3 Antidepressants
4.1.4 Antipsychotics
4.1.5 Anxiolytics
4.1.6 Drugs for the Treatment of Substance and Alcohol Addiction
4.1.7 Drugs for Childhood and Adolescent Mental Illness
4.1.8 Drugs to Treat Cognitive Disorders
4.1.9 Sleep Disorders
4.1.10 Others
4.2 By Type - Global Mental Disorders Drugs Revenue & Forecasts
4.2.1 By Type - Global Mental Disorders Drugs Revenue, 2018-2023
4.2.2 By Type - Global Mental Disorders Drugs Revenue, 2024-2029
4.2.3 By Type - Global Mental Disorders Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Mental Disorders Drugs Sales & Forecasts
4.3.1 By Type - Global Mental Disorders Drugs Sales, 2018-2023
4.3.2 By Type - Global Mental Disorders Drugs Sales, 2024-2029
4.3.3 By Type - Global Mental Disorders Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Mental Disorders Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Mental Disorders Drugs Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adolescents
5.1.4 Adults
5.2 By Application - Global Mental Disorders Drugs Revenue & Forecasts
5.2.1 By Application - Global Mental Disorders Drugs Revenue, 2018-2023
5.2.2 By Application - Global Mental Disorders Drugs Revenue, 2024-2029
5.2.3 By Application - Global Mental Disorders Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Mental Disorders Drugs Sales & Forecasts
5.3.1 By Application - Global Mental Disorders Drugs Sales, 2018-2023
5.3.2 By Application - Global Mental Disorders Drugs Sales, 2024-2029
5.3.3 By Application - Global Mental Disorders Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Mental Disorders Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Mental Disorders Drugs Market Size, 2022 & 2029
6.2 By Region - Global Mental Disorders Drugs Revenue & Forecasts
6.2.1 By Region - Global Mental Disorders Drugs Revenue, 2018-2023
6.2.2 By Region - Global Mental Disorders Drugs Revenue, 2024-2029
6.2.3 By Region - Global Mental Disorders Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Mental Disorders Drugs Sales & Forecasts
6.3.1 By Region - Global Mental Disorders Drugs Sales, 2018-2023
6.3.2 By Region - Global Mental Disorders Drugs Sales, 2024-2029
6.3.3 By Region - Global Mental Disorders Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Mental Disorders Drugs Revenue, 2018-2029
6.4.2 By Country - North America Mental Disorders Drugs Sales, 2018-2029
6.4.3 US Mental Disorders Drugs Market Size, 2018-2029
6.4.4 Canada Mental Disorders Drugs Market Size, 2018-2029
6.4.5 Mexico Mental Disorders Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Mental Disorders Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Mental Disorders Drugs Sales, 2018-2029
6.5.3 Germany Mental Disorders Drugs Market Size, 2018-2029
6.5.4 France Mental Disorders Drugs Market Size, 2018-2029
6.5.5 U.K. Mental Disorders Drugs Market Size, 2018-2029
6.5.6 Italy Mental Disorders Drugs Market Size, 2018-2029
6.5.7 Russia Mental Disorders Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Mental Disorders Drugs Market Size, 2018-2029
6.5.9 Benelux Mental Disorders Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Mental Disorders Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Mental Disorders Drugs Sales, 2018-2029
6.6.3 China Mental Disorders Drugs Market Size, 2018-2029
6.6.4 Japan Mental Disorders Drugs Market Size, 2018-2029
6.6.5 South Korea Mental Disorders Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Mental Disorders Drugs Market Size, 2018-2029
6.6.7 India Mental Disorders Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Mental Disorders Drugs Revenue, 2018-2029
6.7.2 By Country - South America Mental Disorders Drugs Sales, 2018-2029
6.7.3 Brazil Mental Disorders Drugs Market Size, 2018-2029
6.7.4 Argentina Mental Disorders Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Mental Disorders Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Mental Disorders Drugs Sales, 2018-2029
6.8.3 Turkey Mental Disorders Drugs Market Size, 2018-2029
6.8.4 Israel Mental Disorders Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Mental Disorders Drugs Market Size, 2018-2029
6.8.6 UAE Mental Disorders Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Mental Disorders Drugs Major Product Offerings
7.1.4 Johnson & Johnson Mental Disorders Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Mental Disorders Drugs Major Product Offerings
7.2.4 Pfizer Mental Disorders Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Mental Disorders Drugs Major Product Offerings
7.3.4 Eli Lilly Mental Disorders Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Mental Disorders Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Mental Disorders Drugs Sales and Revenue in Global (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Mental Disorders Drugs Major Product Offerings
7.5.4 AstraZeneca Mental Disorders Drugs Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Mental Disorders Drugs Major Product Offerings
7.6.4 Bristol-Myers Squibb Mental Disorders Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Bristol-Myers Squibb Key News & Latest Developments
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Company Summary
7.7.2 Abbott Laboratories Business Overview
7.7.3 Abbott Laboratories Mental Disorders Drugs Major Product Offerings
7.7.4 Abbott Laboratories Mental Disorders Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Abbott Laboratories Key News & Latest Developments
8 Global Mental Disorders Drugs Production Capacity, Analysis
8.1 Global Mental Disorders Drugs Production Capacity, 2018-2029
8.2 Mental Disorders Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Mental Disorders Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Mental Disorders Drugs Supply Chain Analysis
10.1 Mental Disorders Drugs Industry Value Chain
10.2 Mental Disorders Drugs Upstream Market
10.3 Mental Disorders Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mental Disorders Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Mental Disorders Drugs in Global Market
Table 2. Top Mental Disorders Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Mental Disorders Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Mental Disorders Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Mental Disorders Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Mental Disorders Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Mental Disorders Drugs Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Mental Disorders Drugs Product Type
Table 9. List of Global Tier 1 Mental Disorders Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mental Disorders Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Mental Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Mental Disorders Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Mental Disorders Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Mental Disorders Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Mental Disorders Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Mental Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Mental Disorders Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Mental Disorders Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Mental Disorders Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Mental Disorders Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Mental Disorders Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Mental Disorders Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Mental Disorders Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Mental Disorders Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Mental Disorders Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Mental Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Mental Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Mental Disorders Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Mental Disorders Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Mental Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Mental Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Mental Disorders Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Mental Disorders Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Mental Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Mental Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Mental Disorders Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Mental Disorders Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Mental Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Mental Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Mental Disorders Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Mental Disorders Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Mental Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Mental Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Mental Disorders Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Mental Disorders Drugs Sales, (K Units), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Mental Disorders Drugs Product Offerings
Table 48. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Mental Disorders Drugs Product Offerings
Table 52. Pfizer Mental Disorders Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Eli Lilly Company Summary
Table 55. Eli Lilly Mental Disorders Drugs Product Offerings
Table 56. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. GlaxoSmithKline Company Summary
Table 59. GlaxoSmithKline Mental Disorders Drugs Product Offerings
Table 60. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. GlaxoSmithKline Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Mental Disorders Drugs Product Offerings
Table 64. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Summary
Table 67. Bristol-Myers Squibb Mental Disorders Drugs Product Offerings
Table 68. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Bristol-Myers Squibb Key News & Latest Developments
Table 70. Abbott Laboratories Company Summary
Table 71. Abbott Laboratories Mental Disorders Drugs Product Offerings
Table 72. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Abbott Laboratories Key News & Latest Developments
Table 74. Mental Disorders Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 75. Global Mental Disorders Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Mental Disorders Drugs Production by Region, 2018-2023 (K Units)
Table 77. Global Mental Disorders Drugs Production by Region, 2024-2029 (K Units)
Table 78. Mental Disorders Drugs Market Opportunities & Trends in Global Market
Table 79. Mental Disorders Drugs Market Drivers in Global Market
Table 80. Mental Disorders Drugs Market Restraints in Global Market
Table 81. Mental Disorders Drugs Raw Materials
Table 82. Mental Disorders Drugs Raw Materials Suppliers in Global Market
Table 83. Typical Mental Disorders Drugs Downstream
Table 84. Mental Disorders Drugs Downstream Clients in Global Market
Table 85. Mental Disorders Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Mental Disorders Drugs Segment by Type in 2022
Figure 2. Mental Disorders Drugs Segment by Application in 2022
Figure 3. Global Mental Disorders Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Mental Disorders Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Mental Disorders Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Mental Disorders Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Mental Disorders Drugs Revenue in 2022
Figure 9. By Type - Global Mental Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Mental Disorders Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Mental Disorders Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Mental Disorders Drugs Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Mental Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Mental Disorders Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Mental Disorders Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Mental Disorders Drugs Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Mental Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Mental Disorders Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Mental Disorders Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Mental Disorders Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Mental Disorders Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Mental Disorders Drugs Sales Market Share, 2018-2029
Figure 23. US Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Mental Disorders Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Mental Disorders Drugs Sales Market Share, 2018-2029
Figure 28. Germany Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Mental Disorders Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Mental Disorders Drugs Sales Market Share, 2018-2029
Figure 37. China Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Mental Disorders Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Mental Disorders Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Mental Disorders Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Mental Disorders Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Mental Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Mental Disorders Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Mental Disorders Drugs by Region, 2022 VS 2029
Figure 54. Mental Disorders Drugs Industry Value Chain
Figure 55. Marketing Channels
